PulseAugur / Brief
EN
LIVE 20:08:45

Brief

last 24h
[2/2] 222 sources

Multi-source AI news clustered, deduplicated, and scored 0–100 across authority, cluster strength, headline signal, and time decay.

  1. RESEARCH · 36氪 (36Kr) 中文(ZH) ·

    Shenzhen: 15% subsidy for smart homes and other smart products in 2026, with a maximum subsidy not exceeding 1500 yuan

    Shenzhen is offering a 15% subsidy, capped at 1500 yuan, for purchases of smart home and other smart products in 2026. This initiative aims to encourage consumers to buy new, qualifying items. Separately, J.P. Morgan hosted a summit where Changchun High-Tech's General Manager, Jin Lei, discussed AI's transformative potential in drug development, highlighting AI's role in designing novel enzymes and optimizing research processes. AI

    IMPACT AI is poised to revolutionize traditional drug development, potentially shortening research cycles and reducing costs, while government subsidies may boost adoption of smart consumer products.

  2. COMMENTARY · 36氪 (36Kr) 中文(ZH) ·

    Sansheng Pharmaceutical Jin Lei: AI will subvert traditional pharmaceutical logic in the future

    Jin Lei, founder of Genesci Pharmaceutical, stated at a J.P. Morgan summit that AI will revolutionize traditional pharmaceutical development. Genesci has leveraged AI to design innovative enzymes that overcome drug resistance, with one product for bacterial vaginosis entering Phase I clinical trials. The company has seen a 50% reduction in early research cycles and a 33% decrease in process optimization costs due to AI integration. AI

    IMPACT AI integration is accelerating drug discovery and reducing costs, potentially leading to faster development of new treatments.